Read + Share
Amedeo Smart
Independent Medical Education
Lan C, Shen J, Wang Y, Li J, et al. Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial. J Clin Oncol 2020 Oct 14:JCO2001920. doi: 10.1200/JCO.20.01920.PMID: 33052760
Email
LinkedIn
Facebook
Twitter
Privacy Policy